Quick answer
Therapeutic Plasma Exchange (TPE) is a physician-supervised procedure that removes and replaces plasma. Plasmapheresis describes the underlying process of separating plasma from blood. In a private wellness setting, TPE is consultation-based, screening-led, and not appropriate for every individual.
Definitions, kept simple
Plasmapheresis is the process of separating plasma from the cellular components of blood. Therapeutic Plasma Exchange (TPE) uses that process to remove plasma and replace it with a substitute fluid under medical supervision. PLEX is shorthand often used interchangeably with TPE.
TPE in a private wellness context
In a concierge wellness setting, TPE consultations are reviewed by a physician. Every inquiry begins with intake, prior labs, and a private discussion of goals before any plan is offered.
This is intentionally a slower, screening-led process. TPE is not a walk-in service and is not appropriate for everyone.
What to expect during a consultation
A consultation typically covers your health history, current medications, goals, and any prior testing. If TPE is determined to be a reasonable fit, your provider will explain cadence, prep, and what a typical visit involves.
Where appropriate, TPE may be sequenced with EBO3, IV Therapy, HBOT, or Red Light Therapy as part of a broader plan.
Safety and screening
TPE is a physician-supervised procedure. Screening identifies contraindications — including specific medications, conditions, and recent procedures — before any program is offered. Honest, complete intake makes the screening process work.
Frequently asked
- Is TPE the same as plasmapheresis?
- Plasmapheresis is the underlying separation process. TPE uses that process to remove and replace plasma under medical supervision.
- Is TPE appropriate for everyone?
- No. TPE is not appropriate for every individual. Provider screening confirms fit.
- How do I request a consultation?
- Request a private TPE consultation through our concierge team at either clinic. Every plan starts with screening.
Related services
Ready to talk with our team?
Book a complimentary consultation at our Rancho Palos Verdes or West Palm Beach clinic.
Request a ConsultationRelated reading
More from the EBO2 Therapy and Wellness library.
How Physician-Guided Longevity Care Works
Learn how physician guided longevity care works, from private screening and targeted testing to personalized, provider-guided wellness protocols today.
Read
How EBO2 Therapy Sessions Work in Practice
Learn how ebo2 therapy sessions work with private screening, monitored care, recovery guidance, and personalized planning at concierge wellness clinics.
ReadIV Therapy: A Personalized Wellness Approach
Explore physician-supervised IV therapy, from personalized nutrient selection and screening to recovery, cellular wellness, and concierge care planning.
ReadEstablished therapeutic plasma exchange (TPE) indications in ASFA guidelines are disease-specific. Longevity or general-wellness use in healthy individuals is not an ASFA-endorsed indication, and recent 2025 studies of plasmapheresis-based aging biomarkers are small, use surrogate endpoints, and report conflicting results — some epigenetic clocks even increased.
- ASFA Guidelines on the Use of Therapeutic Apheresis in Clinical Practice — 9th Special Issue
American Society for Apheresis, Journal of Clinical Apheresis (DOI 10.1002/jca.22043, PMID 37017433)
Reference guideline categorizing evidence-based medical indications for therapeutic apheresis including TPE. Wellness/longevity use is not addressed as an endorsed indication.
- Randomized trial of therapeutic plasma exchange plus IVIG on aging biomarkers
Aging Cell (DOI 10.1111/acel.70103)
Small randomized trial of TPE combined with IVIG reporting movement on surrogate aging biomarkers. Not a longevity outcomes trial; results are not proof of extended lifespan or general anti-aging benefit.
- Effects of plasmapheresis on epigenetic aging biomarkers — Scientific Reports 2025
Scientific Reports (Nature) 2025
Different plasmapheresis protocol reporting no epigenetic rejuvenation and increases in some epigenetic clocks. Presented alongside the acel.70103 trial so evidence remains balanced and non-promotional.
References describe general evidence, safety, or regulatory context. They do not establish an individual benefit for any specific person, and they do not validate EBO2's proprietary clinic protocols.
Medical Disclaimer: This article is educational and is not a substitute for medical advice, diagnosis, or treatment. Programs are physician-guided, consultation-based, and personalized after screening. Results vary.
